vs

Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and PAMT CORP (PAMT). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $141.3M, roughly 1.1× PAMT CORP). PAMT CORP runs the higher net margin — -20.7% vs -21.1%, a 0.4% gap on every dollar of revenue. On growth, PAMT CORP posted the faster year-over-year revenue change (-15.1% vs -19.2%). PAMT CORP produced more free cash flow last quarter ($-25.0M vs $-28.6M). Over the past eight quarters, OPKO HEALTH, INC.'s revenue compounded faster (-7.5% CAGR vs -12.0%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

OPK vs PAMT — Head-to-Head

Bigger by revenue
OPK
OPK
1.1× larger
OPK
$148.5M
$141.3M
PAMT
Growing faster (revenue YoY)
PAMT
PAMT
+4.0% gap
PAMT
-15.1%
-19.2%
OPK
Higher net margin
PAMT
PAMT
0.4% more per $
PAMT
-20.7%
-21.1%
OPK
More free cash flow
PAMT
PAMT
$3.6M more FCF
PAMT
$-25.0M
$-28.6M
OPK
Faster 2-yr revenue CAGR
OPK
OPK
Annualised
OPK
-7.5%
-12.0%
PAMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPK
OPK
PAMT
PAMT
Revenue
$148.5M
$141.3M
Net Profit
$-31.3M
$-29.3M
Gross Margin
43.1%
Operating Margin
-25.8%
-27.0%
Net Margin
-21.1%
-20.7%
Revenue YoY
-19.2%
-15.1%
Net Profit YoY
-322.8%
7.4%
EPS (diluted)
$-0.04
$-1.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPK
OPK
PAMT
PAMT
Q4 25
$148.5M
$141.3M
Q3 25
$151.7M
$150.3M
Q2 25
$156.8M
$151.1M
Q1 25
$150.0M
$155.3M
Q4 24
$183.6M
$166.5M
Q3 24
$173.6M
$182.6M
Q2 24
$182.2M
$182.9M
Q1 24
$173.7M
$182.6M
Net Profit
OPK
OPK
PAMT
PAMT
Q4 25
$-31.3M
$-29.3M
Q3 25
$21.6M
$-5.6M
Q2 25
$-148.4M
$-9.6M
Q1 25
$-67.6M
$-8.1M
Q4 24
$14.0M
$-31.6M
Q3 24
$24.9M
$2.4M
Q2 24
$-10.3M
$-2.9M
Q1 24
$-81.8M
$281.0K
Gross Margin
OPK
OPK
PAMT
PAMT
Q4 25
43.1%
Q3 25
32.9%
Q2 25
31.5%
Q1 25
28.4%
Q4 24
46.1%
Q3 24
23.1%
Q2 24
28.4%
Q1 24
24.2%
Operating Margin
OPK
OPK
PAMT
PAMT
Q4 25
-25.8%
-27.0%
Q3 25
31.7%
-3.8%
Q2 25
-38.3%
-7.3%
Q1 25
-44.8%
-5.9%
Q4 24
-18.0%
-22.6%
Q3 24
8.2%
1.3%
Q2 24
-33.9%
-0.4%
Q1 24
-41.2%
-0.4%
Net Margin
OPK
OPK
PAMT
PAMT
Q4 25
-21.1%
-20.7%
Q3 25
14.3%
-3.7%
Q2 25
-94.7%
-6.4%
Q1 25
-45.1%
-5.2%
Q4 24
7.6%
-19.0%
Q3 24
14.3%
1.3%
Q2 24
-5.7%
-1.6%
Q1 24
-47.1%
0.2%
EPS (diluted)
OPK
OPK
PAMT
PAMT
Q4 25
$-0.04
$-1.38
Q3 25
$0.03
$-0.27
Q2 25
$-0.19
$-0.46
Q1 25
$-0.10
$-0.37
Q4 24
$0.02
$-1.44
Q3 24
$0.03
$0.11
Q2 24
$-0.01
$-0.13
Q1 24
$-0.12
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPK
OPK
PAMT
PAMT
Cash + ST InvestmentsLiquidity on hand
$364.4M
$83.7M
Total DebtLower is stronger
$344.0M
$333.9M
Stockholders' EquityBook value
$1.3B
$210.5M
Total Assets
$1.9B
$697.9M
Debt / EquityLower = less leverage
0.27×
1.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPK
OPK
PAMT
PAMT
Q4 25
$364.4M
$83.7M
Q3 25
$412.0M
$115.6M
Q2 25
$267.3M
$117.3M
Q1 25
$428.8M
$102.7M
Q4 24
$426.6M
$110.7M
Q3 24
$400.1M
$92.3M
Q2 24
$40.6M
$114.0M
Q1 24
$75.6M
$125.8M
Total Debt
OPK
OPK
PAMT
PAMT
Q4 25
$344.0M
$333.9M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
$325.6M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$350.1M
Stockholders' Equity
OPK
OPK
PAMT
PAMT
Q4 25
$1.3B
$210.5M
Q3 25
$1.3B
$239.5M
Q2 25
$1.3B
$244.9M
Q1 25
$1.3B
$269.6M
Q4 24
$1.4B
$277.5M
Q3 24
$1.4B
$308.9M
Q2 24
$1.4B
$306.7M
Q1 24
$1.3B
$314.6M
Total Assets
OPK
OPK
PAMT
PAMT
Q4 25
$1.9B
$697.9M
Q3 25
$2.0B
$715.2M
Q2 25
$2.0B
$707.9M
Q1 25
$2.1B
$712.6M
Q4 24
$2.2B
$741.7M
Q3 24
$2.3B
$756.7M
Q2 24
$2.0B
$733.5M
Q1 24
$2.0B
$746.4M
Debt / Equity
OPK
OPK
PAMT
PAMT
Q4 25
0.27×
1.59×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
1.17×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPK
OPK
PAMT
PAMT
Operating Cash FlowLast quarter
$-25.9M
$-5.8M
Free Cash FlowOCF − Capex
$-28.6M
$-25.0M
FCF MarginFCF / Revenue
-19.3%
-17.7%
Capex IntensityCapex / Revenue
1.8%
13.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-190.8M
$-23.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPK
OPK
PAMT
PAMT
Q4 25
$-25.9M
$-5.8M
Q3 25
$-34.6M
$5.9M
Q2 25
$-83.4M
$12.2M
Q1 25
$-34.6M
$5.0M
Q4 24
$-44.4M
$15.2M
Q3 24
$-77.1M
$15.5M
Q2 24
$-26.4M
$18.7M
Q1 24
$-35.6M
$9.6M
Free Cash Flow
OPK
OPK
PAMT
PAMT
Q4 25
$-28.6M
$-25.0M
Q3 25
$-37.8M
$2.5M
Q2 25
$-86.7M
$5.9M
Q1 25
$-37.7M
$-6.8M
Q4 24
$-49.8M
$-39.9M
Q3 24
$-85.0M
$-33.6M
Q2 24
$-33.7M
$4.1M
Q1 24
$-40.0M
$-12.2M
FCF Margin
OPK
OPK
PAMT
PAMT
Q4 25
-19.3%
-17.7%
Q3 25
-24.9%
1.7%
Q2 25
-55.3%
3.9%
Q1 25
-25.2%
-4.4%
Q4 24
-27.1%
-24.0%
Q3 24
-49.0%
-18.4%
Q2 24
-18.5%
2.2%
Q1 24
-23.0%
-6.7%
Capex Intensity
OPK
OPK
PAMT
PAMT
Q4 25
1.8%
13.6%
Q3 25
2.1%
2.3%
Q2 25
2.1%
4.2%
Q1 25
2.1%
7.6%
Q4 24
2.9%
33.1%
Q3 24
4.6%
26.9%
Q2 24
4.0%
8.0%
Q1 24
2.6%
12.0%
Cash Conversion
OPK
OPK
PAMT
PAMT
Q4 25
Q3 25
-1.60×
Q2 25
Q1 25
Q4 24
-3.17×
Q3 24
-3.10×
6.44×
Q2 24
Q1 24
34.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

PAMT
PAMT

Freight Transportation Service$123.1M87%
Fuel Surcharge$18.2M13%

Related Comparisons